Abpro Holdings, Inc. (ABPO)
OTCMKTS · Delayed Price · Currency is USD
0.2185
+0.0105 (5.05%)
At close: Aug 18, 2026
Abpro Holdings Market Cap
Abpro Holdings has a market cap or net worth of $1.29 million as of August 19, 2026. Its market cap has decreased by -93.96% in one year.
Market Cap
1.29M
Enterprise Value
-2.23M
Revenue
n/a
Ranking
n/a
PE Ratio
0.43
Stock Price
$0.22
ChartMarket Cap Chart
Since March 9, 2022, Abpro Holdings's market cap has decreased from 4.10B to 1.29M, a decrease of -99.97%. That is a compound annual growth rate of -83.70%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 18, 2026 | 1.29M | -88.79% |
| Dec 31, 2025 | 11.49M | -87.30% |
| Dec 31, 2024 | 90.44M | -97.94% |
| Dec 22, 2023 | 4.38B | 3.83% |
| Dec 30, 2022 | 4.22B | 2.93% |
| Mar 9, 2022 | 4.10B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bio-Path Holdings | 2.04M |
| AXIM Biotechnologies | 1.67M |
| Sirona Biochem | 1.35M |
| Neon Bloom | 1.27M |
| CERo Therapeutics Holdings | 1.04M |
| Evofem Biosciences | 997.16K |
| Avenue Therapeutics | 848.78K |
| Emmaus Life Sciences | 807.17K |